Los puntos clave no están disponibles para este artículo en este momento.
In adults with influenza A or B virus infections, direct administration of a selective neuraminidase inhibitor, zanamivir, to the respiratory tract is safe and reduces symptoms if begun early.
Hayden et al. (Thu,) studied this question.